Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Nov 19, 2022 9:45am
348 Views
Post# 35112453

Prometics scientists presented great results re plasma produ

Prometics scientists presented great results re plasma produ

Like ryplasim (patients got over 5000 treatments with excellent results) also prometic patented plasma fractionating technology which is much better than the old Cohn process (look at potential of ivig) also presented great results re small molecules like 4050 results where better in human trials than they expected 

then there's takeover that was well planned starting in 2018 and ivig writedown of 150 million in early 2019 starting takeover and THEY GET RID OF PIERRE KAURIN,OUR LEAD SCIENTIST LYNNE GAGNON AND JOHN MORAN  AND THEY ESSENTIALLY STOPPED STUDIES  ,SELL ASSETS PAID THEMSELVES HUGE SAKARIES PAID BACK THEIR LOANS AND

SELL PLASMA DIVISION FOR MINIMAL AMOUNT WEEKS BEFORE FDA APPROVED RYPLASIM 

all retail investors invested in prometics because of ALL great results and potential that was presented to them via news releases and at agm's 3 years before takeover 

who will judge believe prometic scientist/ceo or people who replaced them AFTER takeover

<< Previous
Bullboard Posts
Next >>